Viewing Study NCT05870657


Ignite Creation Date: 2025-12-24 @ 6:58 PM
Ignite Modification Date: 2025-12-31 @ 8:19 AM
Study NCT ID: NCT05870657
Status: COMPLETED
Last Update Posted: 2023-05-23
First Post: 2023-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adherence and Persistence to Inclisiran Among Early Users in Germany
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module